Novasep (Pompey, France: www.novasep.com), a producer of active pharmaceutical ingredients (APIs) and purification technologies for the life science industries, has announced the acquisition of Henogen, a contract manufacturing
organization offering bioprocess development and manufacturing services from the cell bank to the supply of clinical products. The move adds a complementary range of upstream processing capabilities and services to Novasep’s downstream processing capabilities. Financial terms of the transaction were not disclosed.
Novasep acquires Henogen
| By Dorothy Lozowski